A detailed history of Ronald Blue Trust, Inc. transactions in Penumbra Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 509 shares of PEN stock, worth $122,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
509
Previous 56 808.93%
Holding current value
$122,343
Previous $10,000 880.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.64 - $210.12 $74,128 - $95,184
453 Added 808.93%
509 $98,000
Q2 2024

Jul 18, 2024

BUY
$172.27 - $223.95 $9,647 - $12,541
56 New
56 $10,000
Q4 2023

Jan 18, 2024

BUY
$181.44 - $260.22 $544 - $780
3 New
3 $1,000
Q1 2023

Apr 17, 2023

BUY
$220.43 - $278.69 $3,306 - $4,180
15 New
15 $3,000
Q3 2022

Oct 21, 2022

SELL
$120.36 - $205.88 $1,925 - $3,294
-16 Reduced 64.0%
9 $1,000
Q2 2022

Aug 09, 2022

BUY
$116.09 - $227.33 $2,902 - $5,683
25 New
25 $6,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.